RESUMEN
Intra-operative blood cell salvage (IOCS) is mainly avoided in onco surgery due to the suspicion that it could increase metastasis' risk. We simulated IOCS followed by leucodepletion: HCT116 (human colorectal cancer) cells were inoculated into packed red blood cells units, and their distribution was evaluated, step-by-step, by flow cytometry and immunohistochemistry. Most of HCT116 cells were lost during washing, and almost completely removed after filtration. IOCS plus leucodepletion could be of great advantage for oncological patients, where allogenic blood transfusion could influence tumour progression.
Asunto(s)
Neoplasias/cirugía , Reacción a la Transfusión/prevención & control , Seguridad de la Sangre , Transfusión de Sangre Autóloga , Citometría de Flujo , Células HCT116 , Humanos , Recuperación de Sangre Operatoria , Trasplante HomólogoRESUMEN
Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder characterized by a lifelong elevation in the concentration of low-density lipoprotein (LDL) bound cholesterol in blood by cholesterol deposits and by early coronary artery disease. The LDL apheresis technique has been introduced with the goal of reducing LDL cholesterol levels, thereby preventing the development of atherosclerosis. The literature on LDL apheresis reports 2 different facets, the therapeutic aspect associated with the lessening of LDL concentration and the initiation of a peroxidation process associated with the biocompatibility of the artificial membrane. Lipid and protein peroxidation gives rise to toxic and atherogenic hydroperoxide, mostly lipid hydroperoxides, and derivative compounds, which may offset the benefit of the procedure. In this paper, plasma hydroperoxide levels are determined along with the elevation of the serum and LDL antioxidant status in hypercholesterolemic patients before and following repeated LDL apheresis sessions. Hydroperoxide concentration has been expressed both in terms of plasma volume and LDL concentration. A highly significant increase in LDL lipid hydroperoxides is demonstrated when expressed in terms of LDL concentration and is associated with the LDL apheresis procedure. The usefulness of antioxidant supplementation in LDL apheresis is discussed.
Asunto(s)
Antioxidantes/análisis , Eliminación de Componentes Sanguíneos , Hiperlipoproteinemia Tipo II/terapia , Peróxidos Lipídicos/sangre , Lipoproteínas LDL/sangre , Vitamina E/sangre , beta Caroteno/sangre , Adulto , Antioxidantes/uso terapéutico , Materiales Biocompatibles , Eliminación de Componentes Sanguíneos/instrumentación , Eliminación de Componentes Sanguíneos/métodos , Estudios de Casos y Controles , Colesterol/sangre , LDL-Colesterol/sangre , LDL-Colesterol/metabolismo , Enfermedad de la Arteria Coronaria/etiología , Enfermedad de la Arteria Coronaria/prevención & control , Femenino , Estudios de Seguimiento , Humanos , Hiperlipoproteinemia Tipo II/sangre , Peroxidación de Lípido , Masculino , Membranas Artificiales , Persona de Mediana Edad , Peróxidos/sangre , Triglicéridos/sangre , Vitamina A/sangre , Vitamina E/uso terapéutico , beta Caroteno/uso terapéuticoRESUMEN
OBJECTIVE: To investigate the effects of desferrioxamine (DFO) infusion on chronic disease anemia (CDA) of rheumatoid arthritis (RA) by evaluating interleukin-6 (IL-6) and erythropoietin (EPO) production. PATIENTS AND METHODS: Five patients with RA and CDA (group I) were treated with DFO, 500 mg daily, through a continuous 10-h subcutaneous infusion 5 days a week for 4 weeks. One month after withdrawal, DFO was resumed in all five group I patients (group II) with an increase to 1 g daily following the previous treatment schedule. Clinical and laboratory parameters were evaluated weekly during the two study periods. Serum EPO was measured by radioimmunoassay. IL-6 was detected by the enzyme-linked immunoabsorbent assay method. RESULTS: No significant variations in hematological parameters, IL-6 or EPO levels were observed in group I patients. After 1 week of DFO 1 g daily, reticulocyte counts and EPO improved significantly. Hemoglobin and hematocrit rose significantly after 3 weeks of 1 g daily DFO therapy. Four weeks after DFO withdrawal, EPO, reticulocyte counts, hemoglobin and hematocrit returned to baseline levels. A significant improvement in the clinical parameters of disease activity was observed, particularly in group II patients. CONCLUSION: DFO improves CDA in RA patients. The beneficial effects on erythropoiesis seem to be related to improved EPO responsiveness to the anemia.
Asunto(s)
Anemia/tratamiento farmacológico , Artritis Reumatoide/complicaciones , Deferoxamina/uso terapéutico , Sideróforos/uso terapéutico , Anemia/metabolismo , Artritis Reumatoide/sangre , Artritis Reumatoide/orina , Enfermedad Crónica , Deferoxamina/administración & dosificación , Relación Dosis-Respuesta a Droga , Ensayo de Inmunoadsorción Enzimática , Eritropoyetina/biosíntesis , Femenino , Ferritinas/sangre , Estudios de Seguimiento , Humanos , Infusiones Parenterales , Interleucina-6/biosíntesis , Hierro/orina , Masculino , Persona de Mediana Edad , Sideróforos/administración & dosificación , Resultado del TratamientoRESUMEN
The radiological changes of the cervical spine were evaluated in 57 patients with psoriatic arthritis and were correlated with clinical, radiological, and immunogenetic features of the disease. Forty patients (70%) showed radiological evidence of the cervical spine being affected by the disease. Two patterns of cervical spine abnormalities were noted. Fifteen patients (26%) had erosive and/or subluxing cervical rheumatoid like lesions; 25 patients (44%) had a more frequently reported pattern similar to ankylosing spondylitis. Although subaxial subluxations were the most frequently observed cervical abnormalities (53%) in the inflammatory subgroup, none of the patients studied had cord compression. Ankylosing cervical spine disease was the only form of axial involvement in nine (36%) of 25 patients with the ankylosing form of psoriatic arthritis. All of these patients had peripheral disease and were B27 negative. Predictors of cervical spine disease patterns were considered using clinical, demographic, and radiological features and HLA antigens. The results of a multivariate analysis showed that the best predictors of inflammatory cervical spine disease are the presence of HLA-B39 and HLA-DR4 antigens, radiocarpal erosions, and the absence of the HLA-DR5 antigen.
Asunto(s)
Artritis Psoriásica/diagnóstico por imagen , Vértebras Cervicales/diagnóstico por imagen , Artritis Psoriásica/inmunología , Análisis Discriminante , Femenino , Antígenos HLA/análisis , Humanos , Masculino , Persona de Mediana Edad , RadiografíaRESUMEN
We studied the epidemiology of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) in a Mediterranean population. Ninety-nine patients with PMR and/or GCA were identified over a 9-year period (1980-1988) in Reggio Emilia, Italy. The average annual incidence of PMR and GCA was 12.7/100,000 and 6.9/100,000, respectively, in a population aged 50 years or older. Frequencies of HLA antigens were determined in 49 patients with PMR and/or GCA who were followed by staff at our rheumatology unit during the 1980-1988 period. When compared with HLA findings in 242 healthy controls, DR4 was not found to be significantly associated with PMR (24% in PMR patients versus 14% in controls). Patients with GCA also showed an increased frequency of DR4 compared with controls (36% versus 14%), but this difference was also not statistically significant. The immunogenetic features of PMR and GCA and the relationship between the immunogenetic and epidemiologic patterns in different populations are discussed.
Asunto(s)
Arteritis de Células Gigantes/epidemiología , Polimialgia Reumática/epidemiología , Anciano , Anciano de 80 o más Años , Distribución de Chi-Cuadrado , Femenino , Arteritis de Células Gigantes/genética , Arteritis de Células Gigantes/inmunología , Antígenos HLA/análisis , Humanos , Incidencia , Italia/epidemiología , Masculino , Persona de Mediana Edad , Polimialgia Reumática/genética , Polimialgia Reumática/inmunologíaAsunto(s)
Brazo , Artritis Psoriásica/complicaciones , Linfedema/etiología , Femenino , Humanos , Persona de Mediana EdadAsunto(s)
Artritis Reumatoide/tratamiento farmacológico , Tiosulfato Sódico de Oro/uso terapéutico , Oro/uso terapéutico , Proteinuria/epidemiología , Femenino , Tiosulfato Sódico de Oro/efectos adversos , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Proteinuria/inducido químicamente , Estudios RetrospectivosRESUMEN
The frequencies of HLA antigens were studied in 101 Italian patients with psoriatic arthritis. The total group showed a significant increase in frequency of A1 and B38, and a reduction of B5 when compared to healthy controls. No association between DR and/or DQw antigens and PA were demonstrated. The comparisons between the clinical subgroups and normal controls revealed a significant association of B38 with asymmetric peripheral arthritis, B27 and B39 with spondylitis (with or without peripheral involvement). When intergroup comparison were made, the patients with spondylitis had an increase in frequency of B27 and DQw3 as compared to those with symmetric and asymmetric peripheral disease. DR4 and DRw53 were associated with earlier age of onset of arthritis. There were also significant associations between DQw3 and severe disease, and between A9, B5 and presence of erosions and joint space narrowing. No association with DR4 was showed in a subgroup of patients with symmetric polyarthritis without DIP involvement.
Asunto(s)
Artritis Psoriásica/inmunología , Antígenos HLA/análisis , Adulto , Artritis Psoriásica/complicaciones , Femenino , Antígenos HLA-A/análisis , Antígenos HLA-B/análisis , Antígenos HLA-DQ/análisis , Antígenos HLA-DR/análisis , Humanos , Italia , Masculino , Persona de Mediana Edad , Espondilitis/complicacionesRESUMEN
A new case of association between Bartter's syndrome and chondrocalcinosis is reported. The patient was shown to have marked hypomagnesemia. Indomethacin and magnesium therapy was started and resulted in increased magnesemia, even if it did not reach normal levels. There was complete remission of articular symptoms and no progression on the radiological picture after 2 years of continuous magnesium and indomethacin therapy. The 7 available family members were studied to assess the possible presence of a familial form of chondrocalcinosis and/or hypomagnesemia. The literature is reviewed and reports of previously described associations between Bartter's syndrome and chondrocalcinosis are summarized. The possible role of hypomagnesemia in predisposing to deposition of calcium pyrophosphate dihydrate crystal in cartilagine is also discussed.
Asunto(s)
Síndrome de Bartter/complicaciones , Condrocalcinosis/complicaciones , Hiperaldosteronismo/complicaciones , Magnesio/sangre , Adulto , Síndrome de Bartter/metabolismo , Pirofosfato de Calcio/análisis , Cartílago/análisis , Condrocalcinosis/metabolismo , Humanos , MasculinoRESUMEN
Fifty-two patients with psoriatic arthritis (PA), treated with auranofin (AF), were entered into a one year prospective, open study. The total group showed a significant increase in frequency of HLA antigens A1 and B38, and a reduction of B5 when compared to healthy controls. There was a remission or an important improvement of disease in the 51% of 45 patients who completed the study. The rate of withdrawal due to side effects was low (8.8%) and the toxicity was mild in nature (diarrhoea and mucocutaneous rash). We prospectively sought predictors of response using HLA antigens, and clinical and laboratory parameters at the beginning of therapy. The only 3 factors found to be related to outcome were duration of psoriasis, physician and patient assessment of disease activity. No laboratory data or HLA specificities could be associated with substantial response to AF therapy.
Asunto(s)
Artritis/tratamiento farmacológico , Auranofina/uso terapéutico , Psoriasis/tratamiento farmacológico , Auranofina/efectos adversos , Humanos , Estudios ProspectivosRESUMEN
Among the population of Reggio Emilia, Italy, 56 patients with polymyalgia rheumatica (PR) and giant cell arteritis (GCA) were identified during the 5-year period 1981-85. The average annual incidence rates of PR and GCA were 12.8 and 8.8 respectively per 100,000 population aged 50 years or older. Forty-nine patients were followed up and the mean duration of follow-up was 32 months. All the patients received steroid therapy. We have evaluated the cumulative probability of requiring continued steroid therapy between patients with PR only, GCA only, and PR associated with GCA using life-table methods with permanent discontinuation of therapy as an end point. The different duration of steroid therapy between these 3 groups did not achieve statistical significance by the method of Lee and Desu. We identified a 5 variable discriminant function that correctly predicted whether the duration of therapy would be longer or shorter than 16 months (median duration of therapy) in 80% of our patients followed up for at least 24 months. The presence of synovitis in PR is also discussed.
Asunto(s)
Arteritis de Células Gigantes/epidemiología , Polimialgia Reumática/epidemiología , Anciano , Anciano de 80 o más Años , Estudios Transversales , Femenino , Estudios de Seguimiento , Arteritis de Células Gigantes/diagnóstico , Arteritis de Células Gigantes/tratamiento farmacológico , Humanos , Italia , Masculino , Persona de Mediana Edad , Polimialgia Reumática/diagnóstico , Polimialgia Reumática/tratamiento farmacológico , Esteroides/uso terapéutico , Sinovitis/etiología , Factores de TiempoRESUMEN
The patient, a 55-year-old man with neuro-Behçet, developed superior vena caval occlusion. Antibodies to cardiolipin were detected in high titres in his serum and a decreased fibrinolysis was also found. It is suggested that anticardiolipin antibodies, perhaps decreasing fibrinolysis, may play an important pathogenic role in some patients with Behçet's disease.